Literature DB >> 26262350

Semantic Web Ontology and Data Integration: a Case Study in Aiding Psychiatric Drug Repurposing.

Chen Liang1, Jingchun Sun1, Cui Tao1.   

Abstract

There remain significant difficulties selecting probable candidate drugs from existing databases. We describe an ontology-oriented approach to represent the nexus between genes, drugs, phenotypes, symptoms, and diseases from multiple information sources. We also report a case study in which we attempted to explore candidate drugs effective for bipolar disorder and epilepsy. We constructed an ontology incorporating knowledge between the two diseases and performed semantic reasoning tasks with the ontology. The results suggested 48 candidate drugs that hold promise for further breakthrough. The evaluation demonstrated the validity our approach. Our approach prioritizes the candidate drugs that have potential associations among genes, phenotypes and symptoms, and thus facilitates the data integration and drug repurposing in psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26262350

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  4 in total

1.  Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression).

Authors:  Abhay Sharma
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

2.  Semantic-Web Architecture for Electronic Discharge Summary Based on OWL 2.0 Standard.

Authors:  Shahram Tahmasebian; Mostafa Langarizadeh; Marjan Ghazisaeidi; Reza Safdari
Journal:  Acta Inform Med       Date:  2016-06-04

3.  An ontology-guided semantic data integration framework to support integrative data analysis of cancer survival.

Authors:  Hansi Zhang; Yi Guo; Qian Li; Thomas J George; Elizabeth Shenkman; François Modave; Jiang Bian
Journal:  BMC Med Inform Decis Mak       Date:  2018-07-23       Impact factor: 2.796

Review 4.  A Semantic-Based Approach for Managing Healthcare Big Data: A Survey.

Authors:  Rafat Hammad; Malek Barhoush; Bilal H Abed-Alguni
Journal:  J Healthc Eng       Date:  2020-11-23       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.